Printer Friendly
The Free Library
19,604,530 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

ArthroCare Completes Acquisition of Parallax Medical.


Business Editors/Health/Medical Writers

SUNNYVALE, Calif.--(BUSINESS WIRE)--Jan. 29, 2004

Strategic Move Expands Company's Interventional Spine Product Line

and Propels ArthroCare into Significant New Market Segment

ArthroCare Corp. (Nasdaq:ARTC ARTC Arthrocare Corp (stock symbol)
ARTC Australian Rail Track Corporation
ARTC Air Route Traffic Control
ARTC Association de la Recherche Theatrale au Canada
ARTC Andean Root and Tuber Crops
), a multi-business medical device company that develops products based on its patented Coblation(R) technology, today announced it has completed the acquisition of Medical Device Alliance, Inc. and its wholly owned subsidiary Wholly Owned Subsidiary

A subsidiary whose parent company owns 100% of its common stock.

Notes:
In other words, the parent company owns the company outright and there are no minority owners.
 Parallax parallax (pâr`əlăks), any alteration in the relative apparent positions of objects produced by a shift in the position of the observer. In astronomy the term is used for several techniques for determining distance.  Medical, Inc., a leader in products for bone access, percutaneous injection of bone cement and bone augmentation in the spine. Physicians use Parallax products during a variety of orthopedic procedures, including treatments for vertebral compression fractures vertebral compression fracture Compression fracture of back Orthopedics A traumatic fracture of a vertebral body which may occur in a background of osteoporosis or malignancy and cause kyphosis and spinal cord pressure. See Herniated disk.  caused by osteoporosis or spinal tumors.

ArthroCare acquired Parallax for $28 million in cash and future revenue milestone payments. The company expects the acquisition to contribute approximately $7-8 million in product sales during the year, break even in fiscal 2004 and be accretive thereafter.

"The Parallax acquisition is a critical component of our expanded interventional spine strategy," said Michael A. Baker Michael Allen Baker (Captain, USN, Ret.) is the International Space Station Program Manager for International and Crew Operations, at NASA's Johnson Space Center. He is responsible for the coordination of program operations, integration and flight crew training and support , president and chief executive officer (CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board. ) for ArthroCare. "It enables us to quickly enter a significant new market segment in which Parallax plays a pioneering role. Parallax has a full range of market-leading products, a rich pipeline of products under development and a strong intellectual property portfolio. We look forward to leveraging these competitive advantages to further penetrate the interventional spine market."

"I am very proud of the Parallax team who pioneered the treatment of vertebral compression fractures and helped enhance the quality of life for many patients," said Howard Preissman, CEO of Parallax. "ArthroCare's Coblation technology, combined with our market-leading products, enables our customers to improve outcomes for a wider variety of patients with spinal injuries."

About ArthroCare

ArthroCare Corp. (www.arthrocare.com), headquartered in Sunnyvale, Calif., is a multi-business medical device company that develops, manufactures and markets minimally invasive soft tissue surgical products based on its patented Coblation technology. Coblation uses low-temperature radiofrequency energy to gently and precisely dissolve rather than burn soft tissue, minimizing damage to healthy tissue. ArthroCare targets a multi-billion dollar market opportunity across several medical specialties, significantly improving surgical procedures and enabling new, minimally invasive procedures. ArthroCare's Coblation-based devices have been used in more than two million surgical procedures worldwide. The company has developed and marketed Coblation-based products for arthroscopic, spine/neurologic, ear, nose and throat, cosmetic, urologic, gynecologic gynecologic /gy·ne·co·log·ic/ (gi?ne-) (jin?e-kah-loj´ik) pertaining to the female reproductive tract or to gynecology.  and laparoscopic/general surgical procedures, and continues research in other areas.

Safe Harbor Safe Harbor

1. A legal provision to reduce or eliminate liability as long as good faith is demonstrated.

2. A form of shark repellent implemented by a target company acquiring a business that is so poorly regulated that the target itself is less attractive.
 Statements

Except for historical information, this press release includes forward-looking statements. These statements include, but are not limited to, the expectations regarding trends in newly commercialized markets, the company's belief that certain surgical products and procedures will enhance achievement of the company's long-term potential, the sustainability of growth rates Growth Rates

The compounded annualized rate of growth of a company's revenues, earnings, dividends, or other figures.

Notes:
Remember, historically high growth rates don't always mean a high rate of growth looking into the future.
 in certain markets, the effect of anticipated government regulatory clearances, continued success of product diversification efforts, opportunities to execute strategic initiatives, and other statements that involve risks and uncertainties. These risks and uncertainties include, but are not limited to, the fact that the company's operating results will fluctuate, the market price of the company's stock may be highly volatile, the sustainability of the company's growth rate, continued success of market diversification efforts. These and other risks and uncertainties are detailed from time to time in the company's Securities and Exchange Commission filings, including ArthroCare's Form 10-K Form 10-K

A report required by the SEC from exchange-listed companies that provides for annual disclosure of certain financial information.


Form 10-K

See 10-K.
 for the year ended December 31, 2002 and the 10-Q for the quarter ended September 30, 2003. Forward-looking statements are indicated by words or phrases such as "anticipates," "estimates," "projects," "believes," "intends," "expects" and similar words and phrases Words and Phrases®

A multivolume set of law books published by West Group containing thousands of judicial definitions of words and phrases, arranged alphabetically, from 1658 to the present.
. Actual results may differ materially from management plans.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Jan 29, 2004
Words:591
Previous Article:Law Enforcement Officers Partner with Save Mart Supermarkets to Raise $100,000 for Special Olympics Northern California.
Next Article:Olin's Fourth Quarter Results Better Than Expected; Announces Decision to Relocate Corporate Headquarters to Illinois; Declares $.20 Per Share...
Topics:



Related Articles
ArthroCare Moves to Acquire Distributors in United Kingdom and Germany; Purchases of Atlantech Medical Devices and Atlantech GmbH Accelerate...
ArthroCare Acquires Austrian Distributor; Purchase of Atlantech Medizinische Produkte Vertriebs-GmbH furthers company's direct sales strategy in key...
ArthroCare Secures Exclusive Rights to Distribute Biocomposites' BiLok Absorbable Tissue Fixation Technology in United States.
ArthroCare to Acquire Interventional Spine Pioneer; Strategic Move Propels Company Into New Market Segment.
ArthroCare Introduces Breakthrough Coblation Device for New Spinal Application; New CAVITY SpineWand Dissolves Tissue Growths in the Spine.
ArthroCare Reports Record Revenues of $32.5 Million for the Fourth Quarter; Fiscal 2003 Revenues Grow 34 Percent to $118.9 Million with EPS Of $0.34.
ArthroCare Announces Live Webcast of Coblation Tonsillectomy from Georgetown University Hospital.
ArthroCare Announces New Business Strategy to Expand Presence in Spine Surgeon Market.
ArthroCare Expands Sports Medicine Product Lines for Knee and Shoulder Surgery.
ArthroCare Reports Revenue Growth of 31 Percent for the First Quarter; Recurring EPS of $0.11 Reduced by $1.2 Million Non-Recurring Acquisition...

Terms of use | Copyright © 2012 Farlex, Inc. | Feedback | For webmasters | Submit articles